{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/KLYG"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KLYG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLYG\",,,,,undefined,":{"symbol":"KLYG","market":"US","secType":"STK","nameCN":"Kelyniam Global, Inc.","latestPrice":0.12,"timestamp":1749830666408,"preClose":0.1,"halted":0,"volume":2500,"delay":15,"floatShares":49718400,"shares":49718400,"eps":-0.007359,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"06-13 12:04:26 EDT Delay","open":0.10095,"high":0.12,"low":0.092,"amount":252.95,"amplitude":0.28,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.007359,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749859200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"PINK","adjPreClose":0.1,"volumeRatio":0.194971},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KLYG\",,,,,undefined,":{"symbol":"KLYG","floatShares":49718400,"roa":"-9.25%","roe":"-31.64%","lyrEps":-0.007359,"volumeRatio":0.194971,"shares":49718400,"dividePrice":0,"high":0.12,"amplitude":0.28,"preClose":0.1,"low":0.092,"week52Low":0.0601,"pbRate":"9.63","psRate":"2.23","week52High":0.39,"institutionHeld":0,"latestPrice":0.12,"eps":-0.007359,"divideRate":0,"volume":2500,"delay":15,"ttmEps":-0.007359,"open":0.10095,"prevYearClose":0.17,"prevWeekClose":0.1389,"prevMonthClose":0.14,"prevQuarterClose":0.1795,"fiveDayClose":0.1389,"twentyDayClose":0.18,"sixtyDayClose":0.2},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/KLYG\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KLYG\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534267511","title":"Press Release: Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2534267511","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534267511?lang=en_us&edition=fundamental","pubTime":"2025-05-12 12:00","pubTimestamp":1747022400,"startTime":"0","endTime":"0","summary":"CANTON, Conn., May 12, 2025 /PRNewswire/ -- Kelyniam Global, Inc. , a leading manufacturer of custom cranial and craniofacial implants, today announced its financial results for the first quarter ended March 31, 2025, and highlighted a new partnership to drive future growth.-- Total revenue of $624,910, compared to $957,447, a decrease of 34.7%.-- Operating loss of $, compared to an operating profit of. \"Kelyniam experienced a challenging first quarter due to seasonal variability and the timing of surgical schedules, which delayed revenue recognition,\" said Ross Bjella, CEO of Kelyniam. \"To address these challenges, we strengthened our sales organization by appointing Alex Rivero as National Sales Director and plan to onboard up to 10 additional distributors in 2025. Our commitment to delivering custom implants within 24-48 hours, combined with strategic partnerships, positions us for improved performance.\". Osteopore's CEO, Dr. Yujing Lim said, \"Kelyniam has demonstrated its ability t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSX.AU","BK4588","BK4022","KLYG","TM","03160","BK4232","BK4604","BK4099","BK4555","BK7126","R","BK4585"],"gpt_icon":0},{"id":"2520552602","title":"Kelyniam Achieves Record Revenue & Profitability for 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2520552602","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520552602?lang=en_us&edition=fundamental","pubTime":"2025-03-17 12:00","pubTimestamp":1742184005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nTUA4ZYFNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLYG"],"gpt_icon":0},{"id":"2505287291","title":"Kelyniam Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2505287291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505287291?lang=en_us&edition=fundamental","pubTime":"2025-01-21 13:00","pubTimestamp":1737435603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA7RHWSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLYG"],"gpt_icon":0},{"id":"2491636418","title":"Kelyniam Global, Inc., (\"Klyg\") Announces Private Investment to Public Entity (\"Pipe\") Closure of Securities Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2491636418","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491636418?lang=en_us&edition=fundamental","pubTime":"2024-12-16 13:01","pubTimestamp":1734325264,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nTUAGL8F4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KLYG"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KLYG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-05-18","symbol":"KLYG","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1621310400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2021-04-02","symbol":"KLYG","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1617336000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-11-16","symbol":"KLYG","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1605502800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-05-18","symbol":"KLYG","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1589774400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-12-13","symbol":"KLYG","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1576213200000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KLYG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KLYG\",market:\"US\",delay:false,,,undefined,":{}}}